VanEck Vectors Valuation Overview

BBH -- USA Etf  

USD 125.97  1.51  1.21%

VanEck Vectors Biotech has current Real Value of $126.73 per share. The regular price of the etf is $125.97. At this time the etf appears to be fairly valued. Macroaxis measures value of VanEck Vectors Biotech from inspecting the etf fundamentals such as Number of Employees of 6, Five Year Return of 10.70% and Price to Earning of 17.66times as well as reviewing its technical indicators and Probability Of Bankruptcy. In general, we recommend to buy undervalued stocks and to dispose of overvalued stocks since at some point securities prices and their ongoing real values will draw towards each other.
Horizon     30 Days    Login   to change
VanEck Vectors Biotech ETF is rated below average in one year return as compared to similar ETFs. It is fifth largest ETF in price to earning as compared to similar ETFs reporting about  8.96  of Price to Earning per One Year Return.

Current Market Valuation

VanEck Vectors Biotech Valuation Boundaries

Fairly Valued
October 21, 2018
Market Value
Real Value
Target Odds
VanEck Vectors is not too risky asset. Calculation of real value of VanEck Vectors Biotech is based on 1 month time horizon. Increasing VanEck Vectors Biotech time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.
Check also Trending Equities. Please also try Transaction History module to view history of all your transactions and understand their impact on performance.